Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sprout Group was a prominent venture capital firm, originally established in 1969 as the venture affiliate of Donaldson, Lufkin & Jenrette (DLJ) and later becoming part of Credit Suisse. The firm was a pioneer in healthcare and life sciences investing, managing several influential funds under the "Sprout Capital" name, including Sprout Capital VII, VIII, and IX. In the early 2000s, the firm shifted its focus exclusively to the healthcare sector before spinning off its healthcare investment team to form Sprout Healthcare Ventures. Throughout its history, Sprout Group was a major backer of numerous successful biotechnology, medical device, and healthcare technology companies, playing a critical role in the development of the modern life sciences industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sprout Capital.